EcoDrugPlus

Estrogen Receptor 1

Ensembl ID : ENSSMAG00000016212
Gene Symbol: ESR1
3 Cross references
215 Possible Orthologues:

Estrogen Receptor 2b

Ensembl ID : ENSSMAG00000003150
Gene Symbol: ESR2B
1 Cross references
208 Possible Orthologues:

Estrogen-Related Receptor Gamma A

Ensembl ID : ENSSMAG00000005851
Gene Symbol: ESRRGA
3 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSMAG00000015718
Gene Symbol: XPO1
3 Cross references
211 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSMAG00000021007
Gene Symbol: XPO1
1 Cross references
224 Possible Orthologues:

Farnesyl Diphosphate Synthase (Farnesyl Pyrophosphate Synthetase, Dimethylallyltranstransferase, Geranyltranstransferase)

Ensembl ID : ENSSMAG00000016292
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSSMAG00000012802
Gene Symbol: FDFT1
2 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSSMAG00000019759
Gene Symbol: FNTB
3 Cross references
209 Possible Orthologues:

Female Protein-Like

Ensembl ID : ENSSMAG00000017477
Gene Symbol: LOC118307955
2 Cross references
354 Possible Orthologues:

Fibroblast Growth Factor Receptor 1a

Ensembl ID : ENSSMAG00000002217
Gene Symbol: FGFR1A
3 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSSMAG00000011669
Gene Symbol: FGFR2
3 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSSMAG00000006801
Gene Symbol: FGFR3
1 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).